1.Effect of Ginkgo Biloba Extract on coronary blood flow in patients with coronary artery disease
Yuzhou WU ; Shuqin LI ; Xiuguang ZU ; Jun DU ; Fengfei WANG
Chinese Traditional Patent Medicine 1992;0(01):-
AIM: To investigate the effect of Ginkgo Biloba Extract on coronary blood flow in patients with coronary artery disease(CAD). METHODS: Ninety CAD patients confirmed by cardioangiography were randomly assigned to Ginkgo Biloba Extract Injection group(n=45) and control groups(n=45).Before and after intravenous administration,the distal left anterior descending coronary artery(LAD) flow was measured by transthoracic Doppler echocardiography. RESULTS: Ginkgo Biloba Extract Injection treatment demonstrated significant improvement in diastolic peak velocity,systolic peak velocity and diastolic time velocity integral(P0.05). CONCLUSION: CAD patients in the treatment of Ginkgo Biloa Extract lead to the increase in LAD blood flow.
2.Value of combined echocardiography and brain natriuretic peptide levels in acute pulmonary embolism treated by thrombolysis
Suyun LIU ; Ruining ZHANG ; Xiuguang ZU ; Yuming HAO ; Jinming LIU ; Yongjun LI
Chinese Journal of Ultrasonography 2011;20(3):213-215
ObjectiveTo explore the value of combined echocardiography and brain natriuretic peptide (BNP) levels in acute pulmonary embolism (APE) treated by thrombolysis.Methods Echocardiography,pulmonary ventilation-perfusion imaging and plasma BNP levels were performed before thrombolysis and 24 - 48 h after thrombolysis in 31 patients with diagnosis of APE and signs of right ventricular pressure overload.Results Twenty-six patients with thrombolysis effective,after thrombolysis,the pulmonary artery systolic pressure decreased from (57.3 ± 18.2)mm Hg to (40.4 ± 15.4)mm Hg (P= 0.003) ,the right ventricular diastolic diameter reduced from (40.6 ± 6.1)mm to (35.4 ± 6.0)mm (P <0.01) ,the pulmonary artery diameter reduced from (27.2 ± 4.9)mm to (22.5 ± 4.4)mm (P = 0.004) ,the left ventricular diastolic diameter increased from (42.4 ± 7.2)mm to (43.1 ± 6.9)mm (P = 0.42),septal contradiction were reduced from 20 cases to 10 cases (P = 0.02),plasma BNP levels decreased from (278.8 ± 43.3)ng/L to (119.1 ± 40.4)ng/L (P = 0.000 01).Five patients with thrombolysis ineffective,there were no significant changes before and after thrombolytic therapy in the parameters of echocardiography,however,plasma BNP levels increased from (431.8 ± 57.7) ng/L to (496.4 ± 70.3) ng/L(P = 0.03).Plasma BNP levels and pulmonary artery systolic pressure had a better relationship(r = 0.62,P <0.01).Conclusions The pulmonary perfusion and right ventricular function in patients with APE can be rapidly improved by thrombolytic therapy.Combined echocardiography and the BNP levels is a sensitive index in the hemodynamic changes of thrombolytic therapy,and can evaluate the treatment accurately.